Smith Devin Whittemore Insider Trades

Insider Trading History

Track insider trading activity for Smith Devin Whittemore. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
IO Biotech
IO Biotech IOBT
General Counsel
Holding Value $1.72k 140,000 shares
Last Trade
Apr 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 140,000 shares
$1.07
$0.01
IO Biotech
IO Biotech IOBT
General Counsel
Holding Value $208 16,938 shares
Last Trade
Dec 23, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.72k 12,000 shares
$0.81
$0.01
IO Biotech
IO Biotech IOBT
General Counsel
Holding Value $2.28k 185,000 shares
Last Trade
Mar 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$305k 185,000 shares
$1.65
$0.01
IO Biotech
IO Biotech IOBT
General Counsel
Holding Value $60.7 4,938 shares
Last Trade
Aug 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.8k 9,876 shares
$1.80
$0.01
IO Biotech
IO Biotech IOBT
General Counsel
Holding Value $1.85k 150,000 shares
Last Trade
Jan 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$390k 150,000 shares
$2.60
$0.01
Yumanity Therapeutics
Yumanity Therapeutics YMTX
SVP And General Counsel
Holding Value $26.4k 13,961 shares
Last Trade
Dec 02, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.27k 3,116 shares
$1.69
$1.89
Yumanity Therapeutics
Yumanity Therapeutics YMTX
SVP And General Counsel
Holding Value $32.3k 17,077 shares
Last Trade
Jun 03, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.15k 2,923 shares
$1.42
$1.89
Yumanity Therapeutics
Yumanity Therapeutics YMTX
SVP And General Counsel
Holding Value $37.8k 20,000 shares
Last Trade
Dec 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$76.6k 20,000 shares
$3.83
$1.89
Yumanity Therapeutics
Yumanity Therapeutics YMTX
SVP And General Counsel
Holding Value $110k 58,400 shares
Last Trade
Jun 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$946k 58,400 shares
$16.20
$1.89
Minerva Neurosciences
Minerva Neurosciences NERV
SVP And General Counsel
Holding Value $383k 85,000 shares
Last Trade
Oct 13, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$298k 85,000 shares
$3.50
$4.51
Minerva Neurosciences
Minerva Neurosciences NERV
SVP And General Counsel
Holding Value $692k 153,531 shares
Last Trade
Jun 19, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$542k 153,531 shares
$3.53
$4.51
Minerva Neurosciences
Minerva Neurosciences NERV
SVP And General Counsel
Holding Value $187k 41,469 shares
Last Trade
Dec 31, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$295k 41,469 shares
$7.11
$4.51
Minerva Neurosciences
Minerva Neurosciences NERV
SVP And General Counsel
Holding Value $541k 120,000 shares
Last Trade
Dec 11, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$955k 120,000 shares
$7.96
$4.51
Minerva Neurosciences
Minerva Neurosciences NERV
SVP And General Counsel
Holding Value $902k 200,000 shares
Last Trade
Aug 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.59M 200,000 shares
$7.95
$4.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up